Q2 revenue and profit decline; Nagpur plant land purchase approved

Revenue DeclineEbitda Margin CompressionResults View source PDF Explain this filing

DHANUKA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-5.1%Reaction day

₹1440.00

prior close

₹1423.20

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.3%-4.8% vs market

Pesticides & Agrochemicals peers, median of 26sector-0.7%-4.5% vs sector

On the reaction day the stock moved 4.8 pts less than Nifty Microcap 250 and 4.5 pts less than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.5

10m

-0.2

15m

-0.6

30m

-1.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-5.1-0.3-4.8-0.7-4.5

Next day

-9.3+0.7-10.1-0.6-8.7

-8.9-0.0-8.9-1.9-7.0

-10.3-1.7-8.5-3.5-6.8

-7.5-1.3-6.2-4.4-3.1

-9.9-1.7-8.2-5.9-4.1

-9.4-1.1-8.4-7.1-2.3

15d

-16.5-4.0-12.5-10.0-6.5

-13.6-3.3-10.2-5.6-8.0

-18.1-5.5-12.5-9.5-8.5

-22.9-12.0-10.9-16.4-6.5

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved unaudited Q2 and H1 FY26 results; the limited review found no material issue. Q2 revenue was Rs 598.25 crore, down 8.6%, while profit fell 20.0% to Rs 93.97 crore. H1 revenue fell 1.9% to Rs 1,126.54 crore and profit fell 10.2% to Rs 149.47 crore. Operating cash flow was positive at Rs 39.82 crore. The board also approved buying land in Nagpur for a formulation plant.

Likely market impact

Lower Q2 sales and profit may pressure the stock near term. Positive cash flow and planned formulation capacity offer longer-term support.